• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非工作时间入院对中国接受再灌注治疗的卒中患者院内结局的影响。

Impact of Off-Hour Admission on In-Hospital Outcomes for Patients With Stroke Receiving Reperfusion Therapy in China.

作者信息

Liu Zeyu, Yang Kaixuan, Gu Hongqiu, Wei Minping, Feng Xianjing, Yu Fang, Du Yang, Li Zixiao, Xia Jian

机构信息

Department of Neurology, Xiangya Hospital (Z. Liu, M.W., X.F., F.Y., Y.D., J.X.), Central South University, Changsha, Hunan, China.

Clinical Research Center for Cerebrovascular Disease of Hunan Province (Z. Liu, M.W., X.F., F.Y., Y.D., J.X.), Central South University, Changsha, Hunan, China.

出版信息

Stroke. 2024 May;55(5):1359-1369. doi: 10.1161/STROKEAHA.123.046096. Epub 2024 Mar 28.

DOI:10.1161/STROKEAHA.123.046096
PMID:38545773
Abstract

BACKGROUND

The structure and staffing of hospitals greatly impact patient outcomes, with frequent changes occurring during nights and weekends. This retrospective cohort study assessed the impact of admission timing on in-hospital management and outcomes for patients with stroke receiving reperfusion therapy in China using data from a nationwide registry.

METHODS

Data from patients receiving reperfusion therapy were extracted from the Chinese Stroke Center Alliance. Hospital admission time was categorized according to day/evening versus night and weekday versus weekend. Primary outcomes were in-hospital death or discharge against medical advice, hemorrhage transformation, early neurological deterioration, and major adverse cardiovascular events. Logistic regression was performed to compare in-hospital management performance and outcomes based on admission time categories.

RESULTS

Overall, 42 381 patients received recombinant tissue-type plasminogen activator (r-tPA) therapy, and 5224 underwent endovascular treatment (EVT). Patients admitted during nighttime had a higher probability of receiving r-tPA therapy within 4.5 hours from onset or undergoing EVT within 6 hours from onset compared with those admitted during day/evening hours (adjusted odds ratio, 1.04 [95% CI, 1.01-1.08]; =0.021; adjusted odds ratio, 1.72 [95% CI, 1.59-1.86]; <0.001, respectively). However, no significant difference was observed between weekend and weekday admissions for either treatment. No notable differences were noted between weekends and weekdays or nighttime and daytime periods in door-to-needle time for r-tPA or door-to-puncture time for EVT initiation. Furthermore, weekend or nighttime admission did not have a significant effect on the primary outcomes of r-tPA therapy or EVT. Nevertheless, in patients undergoing EVT, a higher incidence of pneumonia was observed among those admitted at night compared with those admitted during day/evening hours (adjusted odds ratio, 1.22 [95% CI, 1.05-1.42]; =0.011).

CONCLUSIONS

Patients admitted at nighttime were more likely to receive r-tPA therapy or EVT within the time window recommended in the guidelines. However, patients receiving EVT admitted at night had an increased risk of pneumonia.

摘要

背景

医院的结构和人员配置对患者的治疗结果有很大影响,夜间和周末经常会发生变化。这项回顾性队列研究利用全国登记处的数据,评估了入院时间对中国接受再灌注治疗的中风患者的院内管理和治疗结果的影响。

方法

从中国卒中中心联盟提取接受再灌注治疗患者的数据。医院入院时间根据白天/晚上与夜间以及工作日与周末进行分类。主要结局包括院内死亡或自动出院、出血转化、早期神经功能恶化和主要不良心血管事件。进行逻辑回归以比较基于入院时间分类的院内管理表现和结局。

结果

总体而言,42381例患者接受了重组组织型纤溶酶原激活剂(r-tPA)治疗,5224例接受了血管内治疗(EVT)。与白天/晚上入院的患者相比,夜间入院的患者在发病后4.5小时内接受r-tPA治疗或在发病后6小时内接受EVT的可能性更高(调整后的优势比,1.04[95%CI,1.01-1.08];P=0.021;调整后的优势比,1.72[95%CI,1.59-1.86];P<0.001)。然而,两种治疗在周末和工作日入院之间均未观察到显著差异。r-tPA的门到针时间或EVT开始的门到穿刺时间在周末和工作日之间或夜间和白天之间均未观察到显著差异。此外,周末或夜间入院对r-tPA治疗或EVT的主要结局没有显著影响。然而,在接受EVT的患者中,夜间入院的患者肺炎发生率高于白天/晚上入院的患者(调整后的优势比,1.22[95%CI,1.05-1.42];P=0.011)。

结论

夜间入院的患者更有可能在指南推荐的时间窗内接受r-tPA治疗或EVT。然而,夜间接受EVT的患者肺炎风险增加。

相似文献

1
Impact of Off-Hour Admission on In-Hospital Outcomes for Patients With Stroke Receiving Reperfusion Therapy in China.非工作时间入院对中国接受再灌注治疗的卒中患者院内结局的影响。
Stroke. 2024 May;55(5):1359-1369. doi: 10.1161/STROKEAHA.123.046096. Epub 2024 Mar 28.
2
Thrombolysis for acute ischaemic stroke.急性缺血性脑卒中的溶栓治疗
Cochrane Database Syst Rev. 2003(3):CD000213. doi: 10.1002/14651858.CD000213.
3
Outcomes of Bridging Intravenous Thrombolysis Versus Endovascular Therapy Alone in Late-Window Acute Ischemic Stroke.静脉溶栓桥接治疗与单纯血管内治疗对急性缺血性脑卒中晚期患者的疗效比较。
Stroke. 2024 Jul;55(7):1767-1775. doi: 10.1161/STROKEAHA.124.046495. Epub 2024 May 15.
4
Interhospital Transfer for Endovascular Stroke Treatment in Canada: Results From the OPTIMISE Registry.加拿大血管内卒中治疗的院际间转移:来自 OPTIMISE 登记研究的结果。
Stroke. 2024 Aug;55(8):2103-2112. doi: 10.1161/STROKEAHA.124.046690. Epub 2024 Jul 22.
5
Endovascular thrombectomy with versus without intravenous thrombolysis for acute ischaemic stroke.急性缺血性卒中血管内血栓切除术联合与不联合静脉溶栓治疗的比较
Cochrane Database Syst Rev. 2025 Apr 24;4(4):CD015721. doi: 10.1002/14651858.CD015721.pub2.
6
Comparing Outcomes of Thrombectomy Versus Intravenous Thrombolysis Based on Middle Cerebral Artery M2 Occlusion Features.比较基于大脑中动脉 M2 闭塞特征的取栓术与静脉溶栓的治疗效果。
Stroke. 2024 Jun;55(6):1592-1600. doi: 10.1161/STROKEAHA.123.044986. Epub 2024 May 24.
7
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
8
Catheter-directed therapies for the treatment of high risk (massive) and intermediate risk (submassive) acute pulmonary embolism.经导管治疗高危(大块)和中危(次大块)急性肺栓塞。
Cochrane Database Syst Rev. 2022 Aug 8;8(8):CD013083. doi: 10.1002/14651858.CD013083.pub2.
9
Sex-Based Analysis of Treatment, Time Metrics, and Outcomes in Acute Ischemic Stroke Patients Treated in the Netherlands.荷兰急性缺血性中风患者治疗、时间指标及预后的性别分析
Cerebrovasc Dis. 2025;54(3):356-362. doi: 10.1159/000540224. Epub 2024 Jul 22.
10
Short-Term Safety and Effectiveness for Tenecteplase and Alteplase in Acute Ischemic Stroke.替奈普酶和阿替普酶治疗急性缺血性卒中的短期安全性和有效性
JAMA Netw Open. 2025 Mar 3;8(3):e250548. doi: 10.1001/jamanetworkopen.2025.0548.

引用本文的文献

1
The value of the CRP-albumin-lymphocyte index (CALLY index) as a prognostic biomarker in acute ischemic stroke.C反应蛋白-白蛋白-淋巴细胞指数(CALLY指数)作为急性缺血性卒中预后生物标志物的价值。
Sci Rep. 2025 Apr 21;15(1):13672. doi: 10.1038/s41598-025-97538-7.